Andreas Strüngmann Net Worth

Pharma investor and entrepreneur
BillionaireBusiness
Estimated net worth
$11B
Source: Forbes Real-Time Billionaires, October 20, 2026. Updated October 24, 2026.

Andreas Strüngmann’s net worth over time

$4.4B: Forbes World's Billionaires List 2019 estimate, 2019$4.4B2019$9.6B: Forbes World's Billionaires List 2020 estimate, 2020$9.6B2020$11B: Forbes World's Billionaires List 2021 estimate, 2021$11B2021$11.9B: Forbes World's Billionaires List 2022 estimate, 2022$11.9B2022$11.5B: Forbes World's Billionaires List 2023 estimate, 2023$11.5B2023$9.8B: Forbes World's Billionaires List 2024 estimate, 2024$9.8B2024$11.3B: Forbes World's Billionaires List 2025 estimate, 2025$11.3B2025$12B: Forbes World's Billionaires List 2026 estimate, 2026$12B2026$11B: Forbes Real-Time Billionaires estimate, Oct 2026. Forbes real-time estimate$11BOct 2026

Only dates with a published estimate are shown. Nothing is filled in between. Tap or hover a bar to see the source.

See the numbers as a table
DateEstimateSource
2019$4.4 billionForbes World's Billionaires List 2019
2020$9.6 billionForbes World's Billionaires List 2020
2021$11 billionForbes World's Billionaires List 2021
2022$11.9 billionForbes World's Billionaires List 2022
2023$11.5 billionForbes World's Billionaires List 2023
2024$9.8 billionForbes World's Billionaires List 2024
2025$11.3 billionForbes World's Billionaires List 2025
2026$12 billionForbes World's Billionaires List 2026
Oct 2026$11 billionForbes Real-Time Billionaires · Forbes real-time estimate

Where the money comes from

Pharmaceuticals

These are the main sources of wealth named in the reporting we cite. No published source breaks the total into exact amounts, so we do not show percentages.

Andreas Strüngmann’s fortune in real-life terms

168,155 years
for the median full-time U.S. worker to earn this much, spending nothing
50,902×
the net worth of the typical U.S. family
1.2%
of Elon Musk's fortune, the biggest on Net Worth Lookup

Based on the Forbes Real-Time Billionaires estimate above. Median full-time U.S. pay is $65,416 a year ($1,258 a week, BLS, Q2 2026), before taxes. Typical (median) U.S. family net worth is $216,100 (Federal Reserve, 2025 Survey of Consumer Finances).

How do you compare to Andreas Strüngmann? New

Type your yearly income and see how you stack up. It runs in your browser: nothing you type is saved or sent anywhere.

Full comparison + share card →

Andreas Strüngmann has an estimated net worth of $11 billion, according to Forbes Real-Time Billionaires, Andreas Strüngmann profile (figures as of October 20, 2026). That is up from $4.4 billion in 2019.

Andreas Strüngmann is a German physician, businessman, and investor in healthcare. After studying medicine in Freiburg, Germany, he worked as a doctor in South Africa. His biggest early business move came in 1986, when he and his twin brother Thomas cofounded generic drugmaker Hexal. The company became a major player in lower-cost medicines, and that business helped build the fortune that later funded a wide range of biotech and pharmaceutical investments.

A second major chapter came through backing BioNTech at an early stage. In 2008, the Strüngmann brothers supported the company with a €136.5 million seed investment in a €150 million round. BioNTech later partnered with Pfizer to make a vaccine for Covid-19. Alongside that stake, the brothers have invested through Santo Holding in biotech, pharma, life sciences, and healthcare companies. Forbes put Andreas Strüngmann's net worth at $11 billion on its real-time tracker on October 20, 2026.

How Andreas Strüngmann built his wealth

Much of Strüngmann's wealth traces back to Hexal, the generic drugmaker he cofounded with his brother in 1986. In 2005, they sold Hexal and their 67.7 percent of U.S. Eon Labs to Novartis for $7.5 billion. That deal made Sandoz the largest generic-drug company in the world. Afterward, Andreas took an executive role at Sandoz, leading regional operations in Europe, Africa and Asia-Pacific.

He and his brother then kept building through investing. Their Santo Holding has backed companies in biotech, pharma, life sciences, and healthcare from Zug, Switzerland. They were also early supporters of BioNTech, putting in €136.5 million during a €150 million seed round in 2008. Other deals in the record include buying 89.6 percent of Südwestbank in 2004, a 2014 purchase of Siemens Audiology Solutions for €2.2 billion with EQT AB, and support for a Conergy capital increase in 2008.

Forbes net worth over time

Forbes tracked a sharp rise in Strüngmann's fortune after the BioNTech investment became far more valuable. Its annual estimates moved from $4.4 billion in 2019 to $9.6 billion in 2020, then $11 billion in 2021 and $11.9 billion in 2022. Forbes later estimated $11.5 billion in 2023 and $9.8 billion in 2024 before raising the figure to $11.3 billion in 2025 and $12 billion in 2026.

The main money story behind those changes is clear in his business history. Forbes says Strüngmann and his brother were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19. At the same time, his wealth still rests on the earlier Hexal sale and a long run of healthcare investing through Santo Holding. Forbes' real-time tracker showed him at $11 billion in October 2026.

Career and money timeline

  1. 1986

    He and his brother cofounded generic drugmaker Hexal.

  2. 2004

    Through Santo Holding, the brothers acquired 89.6 percent of Südwestbank from DZ Bank.

  3. 2005

    They sold Hexal and their 67.7 percent of Eon Labs to Novartis for $7.5 billion.

  4. 2008

    The brothers backed BioNTech with €136.5 million in a €150 million seed round.

  5. 2014

    Santo Holding and EQT AB bought Siemens Audiology Solutions for €2.2 billion.

  6. 2017

    The brothers sold Südwestbank to BAWAG for an undisclosed price.

Andreas Strüngmann net worth FAQ

What is Andreas Strüngmann's net worth?

Andreas Strüngmann's net worth is an estimated $11 billion, according to Forbes Real-Time Billionaires, Andreas Strüngmann profile (October 20, 2026). It is an estimate, not an official figure.

How did Andreas Strüngmann get so rich?

The main sources named in the reporting we cite are: Pharmaceuticals.

How has Andreas Strüngmann's net worth changed?

The earliest published estimate we track is $4.4 billion (2019, Forbes World's Billionaires List 2019). The latest is $11 billion (October 20, 2026).

What companies made Andreas Strüngmann rich?

Hexal was the first big source of wealth, especially after its 2005 sale to Novartis. BioNTech later became another major driver, alongside other healthcare investments through Santo Holding.

Is Andreas Strüngmann self-made?

Yes. Forbes lists him as self-made.